| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 9 |
| 1 | CARBOPLATIN | 8 |
| 2 | PACLITAXEL | 7 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 7 |
| 4 | TACROLIMUS | 7 |
| 5 | CLOPIDOGREL BISULFATE | 6 |
| 6 | MYCOPHENOLATE MOFETIL | 5 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 5 |
| 8 | PEMBROLIZUMAB | 5 |
| 9 | PREDNISONE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM NITROPRUSSIDE | 1 | 0.0026 |
| 1 | ALPROSTADIL | 1 | 0.0003 |
| 2 | CALCIUM FOLINATE | 1 | 0.0002 |
| 3 | RIPRETINIB | 1 | 0.0002 |
| 4 | GANCICLOVIR SODIUM | 2 | 0.0002 |
| 5 | SIROLIMUS | 2 | 0.0001 |
| 6 | ENFORTUMAB VEDOTIN | 1 | 0.0001 |
| 7 | BASILIXIMAB | 1 | 0.0001 |
| 8 | GOLIMUMAB | 1 | 0.0001 |
| 9 | IRINOTECAN HYDROCHLORIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 1 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 6 | 0.0001 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 9 | 0.0000 |
| 4 | Microtubule Inhibitor [EPC] | 7 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 11 | 0.0000 |
| 6 | P2Y12 Platelet Inhibitor [EPC] | 4 | 0.0000 |
| 7 | Penem Antibacterial [EPC] | 1 | 0.0000 |
| 8 | Nucleoside Analog Antiviral [EPC] | 2 | 0.0000 |
| 9 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 2 | 0.0000 |